U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07201025) titled 'Imaging Assessments of ARPKD Kidney Disease Progression' on Sept. 23.
Brief Summary: Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a potentially lethal genetic disorder for which there are currently no disease specific treatments. Clinical trials have been limited by the absence of robust measures of disease progression. The overall goal of this 5 year NIH-funded prospective, observational multicenter study conducted at CC (primary site) and Children's Hospital of Philadelphia (CHOP) (collaborating site) is establish a set of rapid, quantitative, and reproducible novel kidney MRI measures applicable to standard clinical MR...